Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/10/790
Active ingredient: Ambrisentan
Indication: Treatment of idiopathic pulmonary fibrosis
Sponsor: Gilead Sciences International Limited
Flowers Building, Granta Park, Abington, Cambridge CB21 6GT United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/10/2010 Orphan designation EMA/OD/029/10 (2010)6935 of 01/10/2010
23/06/2011 Removal of orphan designation from Community Register